Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07132827) titled 'Efficacy and Safety of SHR-1905 Injection in Subjects With Chronic Rhinosinusitis With Nasal Polyps' on Aug. 13.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor).
Primary Sponsor: Guangdong Hengrui Pharmaceutical Co., Ltd
Condition:
Chronic Rhinosinusitis With Nasal Polyps
Intervention:
Drug: SHR-1905 Injection
Recruitment Status: Not recruiting
Phase: Phase 3
Date of First Enrollment: August 2025
Target Sample Size: 280
Countries of Recru...